On January 30, 2017, the second pair of participants received their first experimental treatment in our new study of MDMA combined with Cognitive Behavioral Conjoint Therapy (CBCT) for PTSD in Charleston, South Carolina. This pair (dyad) was officially enrolled on January 28, 2017. The study will enroll 10 dyads, with one participant diagnosed with PTSD and one concerned significant other who does not have PTSD but does experience psychosocial distress. The primary goal of this study is to develop a combined method of MDMA with CBCT for PTSD. MDMA will be administered to both participants to help facilitate communication and connection between participants and therapists. Learn more…
